Press Release
Chemours Completes Sale of Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific, LLC for $137 Million
The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, announced it completed the sale of its Glycolic Acid Business to PureTech Scientific, LLC, a company founded and backed by Iron Path Capital, a private equity firm focused on lower-middle market inv...
Read More